Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.

Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial page now displays the study record for anti-PD-1 therapy alone or combined with DC-CIK cell therapy in advanced solid tumors, including its design, participant criteria, outcome measures, and record history.SummaryDifference40%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, indicating a site software version update.SummaryDifference0.2%

- Check19 days agoChange DetectedThe study page no longer displays a 403 error and instead shows a general NIH website-transition announcement above an otherwise blank study-record area.SummaryDifference2%

- Check26 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content, with a simple header and a Home link. This indicates that access to the requested resource is blocked.SummaryDifference0.5%

Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.